37 related articles for article (PubMed ID: 12894504)
1. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
Konishi N; Nakamura M; Kishi M; Ishida E; Shimada K; Matsuyoshi S; Nagai H; Emi M
Cancer Sci; 2003 Sep; 94(9):764-8. PubMed ID: 12967473
[TBL] [Abstract][Full Text] [Related]
2. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH.
Ichimura K; Mungall AJ; Fiegler H; Pearson DM; Dunham I; Carter NP; Collins VP
Oncogene; 2006 Feb; 25(8):1261-71. PubMed ID: 16205629
[TBL] [Abstract][Full Text] [Related]
3. Second generation sequencing of the mesothelioma tumor genome.
Bueno R; De Rienzo A; Dong L; Gordon GJ; Hercus CF; Richards WG; Jensen RV; Anwar A; Maulik G; Chirieac LR; Ho KF; Taillon BE; Turcotte CL; Hercus RG; Gullans SR; Sugarbaker DJ
PLoS One; 2010 May; 5(5):e10612. PubMed ID: 20485525
[TBL] [Abstract][Full Text] [Related]
4. MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β.
Wang Y; Chen J; Zhang M; Zhang W; Li M; Zang W; Dong Z; Zhao G
J Cell Mol Med; 2018 Aug; 22(8):3857-3865. PubMed ID: 29726631
[TBL] [Abstract][Full Text] [Related]
5. Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.
Wang Y; Zang W; Du Y; Ma Y; Li M; Li P; Chen X; Wang T; Dong Z; Zhao G
J Transl Med; 2013 Dec; 11():301. PubMed ID: 24314023
[TBL] [Abstract][Full Text] [Related]
6. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma.
Wang Y; Li M; Zang W; Ma Y; Wang N; Li P; Wang T; Zhao G
Cell Oncol (Dordr); 2013 Oct; 36(5):385-94. PubMed ID: 23999873
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells.
Wang M; Wang Y; Zang W; Wang H; Chu H; Li P; Li M; Zhang G; Zhao G
Tumour Biol; 2014 Jan; 35(1):39-46. PubMed ID: 23877371
[TBL] [Abstract][Full Text] [Related]
8. Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.
Klorin G; Rozenblum E; Glebov O; Walker RL; Park Y; Meltzer PS; Kirsch IR; Kaye FJ; Roschke AV
Cancer Genet; 2013 May; 206(5):191-205. PubMed ID: 23830731
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.
Feber A; Xi L; Pennathur A; Gooding WE; Bandla S; Wu M; Luketich JD; Godfrey TE; Litle VR
Ann Thorac Surg; 2011 May; 91(5):1523-30. PubMed ID: 21420070
[TBL] [Abstract][Full Text] [Related]
10. Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study.
Epplein M; Wilkens LR; Tiirikainen M; Dyba M; Chung FL; Goodman MT; Murphy SP; Henderson BE; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):314-20. PubMed ID: 19124514
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
[TBL] [Abstract][Full Text] [Related]
12. A major lung cancer susceptibility locus maps to chromosome 6q23-25.
Bailey-Wilson JE; Amos CI; Pinney SM; Petersen GM; de Andrade M; Wiest JS; Fain P; Schwartz AG; You M; Franklin W; Klein C; Gazdar A; Rothschild H; Mandal D; Coons T; Slusser J; Lee J; Gaba C; Kupert E; Perez A; Zhou X; Zeng D; Liu Q; Zhang Q; Seminara D; Minna J; Anderson MW
Am J Hum Genet; 2004 Sep; 75(3):460-74. PubMed ID: 15272417
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations in human mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q.
Jensen RH; Tiirikainen M; You L; Ginzinger D; He B; Uematsu K; Xu Z; Treseler P; McCormick F; Jablons DM
Anticancer Res; 2003; 23(3B):2281-9. PubMed ID: 12894504
[TBL] [Abstract][Full Text] [Related]
14. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
Bell DW; Jhanwar SC; Testa JR
Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the molecular analysis of human malignant mesothelioma.
De Rienzo A; Testa JR
Clin Ter; 2000; 151(6):433-8. PubMed ID: 11211478
[TBL] [Abstract][Full Text] [Related]
18. Somatic genetic alterations in human malignant mesothelioma (review).
Lee WC; Testa JR
Int J Oncol; 1999 Jan; 14(1):181-8. PubMed ID: 9863027
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
